Pembrolizumab
(Mfr: MSD)(Conc/L: 1 g)
Sodium chloride 0.9%
(Mfr: BRNa)
Remarks:
Physically and chemically stable for 7 days with in vitro PD-1 binding activity retained at 17 to 23°C or 2 to 8°C in light
Ref:
3878